Why Emocog
We create technology that helps sustain brain health
Dementia affects about 10% of the senior population and progresses over a decade. The stage of memory decline before dementia is called Mild Cognitive Impairment (MCI) and progresses overhalf a decade. The prevalence rate is about 25%.
Emocog develops solutions for each stage of dementia, including Cogthera, a cognitive improving digital therapeutics for MCI.
Research
Technology based on world-class scientific results
The results of 20 years of research was published in 5 leading *SCI-indexed journals on brain disease.
*Science Citation Index (SCI): renowned journals carefully selected based on strict criteria among science and technology journals
Solution 1
Emocog builds an ecosystem to care for the entire journey from screening, diagnosis and treatment of dementia.
To overcome the physical constraints of not being able to care for every patient every day, we propose innovative solutions utilizing digital technology.
*Digital treatments and medical applications(DiGA) are virtual medical products that are available as apps for mobile devices or as browser applications. Cogthera DE can quickly enter the market and receive very high insurance rates through these process.
Emocog’s Digital Dementia Solutions
LAUNCH
DATA COLLECTION
& ANALYSIS
DETAILED
DESIGN
PROTOTYPE
& TEST